There is increasing evidence suggesting that adult neural stem cells (NSCs) are a cell of 2 origin of glioblastoma, the most aggressive form of malignant glioma. The earliest stages of 3 hyperplasia are not easy to explore, but likely involve a cross-talk between normal and 4 transformed NSCs. How normal cells respond to this cross-talk and if they expand or are 5 outcompeted is poorly understood. Here we have analysed the interaction of transformed and 6 wild-type NSCs isolated from the adult mouse subventricular zone neural stem cell niche. We 7
Introduction

15
In the adult mammalian brain, neural stem cells (NSCs) can be primarily found in specific 16 neurogenic regions. In rodents these are the subgranular zone (SGZ) of the dentate gyrus 17 (DG) and the subventricular zone (SVZ), which lines the lateral ventricles (Doetsch et al., 18 1999; Quinones-Hinojosa et al., 2006; Sanai et al., 2004) . In the SVZ there are both 19 quiescent NSCs and activated NSCs that coexist in the niche (Quinones-Hinojosa et al., 20 2006) . The quiescent NSC subpopulation make up the majority of NSCs in the adult SVZ and 21 are capable of completely regenerating this niche following anti-mitotic drug treatment 22 (Doetsch et al., 1999; Giachino and Taylor, 2009; Pastrana et al., 2009) . Tight regulation of 23 the switch between these two states is vital to ensure that the pool of NSCs does not 24 accumulate DNA damage or become exhausted over time and therefore understanding how 25 this is achieved is of great interest. One key event in NSC activation is the upregulation of 26 EGFR, which is highly expressed in activated NSCs and progenitor cells but absent in 27 quiescent NSCs. Thus, cell surface expression of EGFR is often used as a marker to 28 differentiate these two populations (Codega et al., 2014; Pastrana et al., 2009) . What 29 feedback mechanisms exist between activated EGFR +ve NSCs and quiescent NSCs to ensure 30 stem cell homeostasis is poorly understood. 31
Over the last couple of decades, evidence has accumulated to suggest that adult NSCs are a 32 cell of origin in certain brain tumours. One possibility is that these cells accumulate driver 33 mutations over time, which compromise the normal controls on their proliferation and 34 migration. These transformed NSCs could then escape the niche and acquire further 35 mutations resulting in tumour formation. This has been hypothesised to be the case in 36 glioblastoma (GBM), the most aggressive subtype of malignant glioma (Louis et al., 2007; 37 Rispoli et al., 2014) . In particular, the discovery of a subpopulation of cells within GBM 38 tumours with stem cell characteristics, known as glioblastoma stem cells (GSCs), has lent 39 weight to this notion. This GSC population in GBM tumours share many common features 40 with adult NSCs, including expression of stem and progenitor markers, such as CD133, 41 SOX2 and Nestin, self-renewal capacity, and the ability to generate multilineage progeny 42 (Cheng et al., 2013; Denysenko et al., 2010; Singh et al., 2003; Singh et al., 2004; Stieber et 43 al., 2014; Zhang et al., 2006) . Most importantly, GSCs are also able to generate tumours in 44 mice which recapitulate all the classical features of GBM, even when injected in very small 45 numbers (Galli et al., 2004; Singh et al., 2004) . For this reason, they are sometimes also 46 referred to as brain tumour initiating cells. 47
Adult NSCs can be isolated from the SVZ of murine brains and cultured as 3D neurospheres 48 or adherent cultures under conditions that promote symmetric self-renewal and prevent 49 differentiation (Conti et al., 2005; Pollard et al., 2006; Pollard et al., 2009 ). Furthermore, by 50
using NSCs engineered with oncogenic drivers, these in vitro culture systems can also be 51 useful to model brain tumour development and cross-comparison with wild-type 52 counterparts. Here we exploit this system to understand how transforming mutations affect 53 the quiescent or activation status of NSCs. We find that transformed NSCs are refractory to 54 quiescent inducing signals. Importantly, we also demonstrate that transformed NSCs signal 55 via Notch and RBPJ to induce a quiescent-like state in surrounding wild-type NSCs. These 56 results therefore provide new insight into how oncogenic mutations affect not only the 57 proliferative potential of transformed cells, but also provide them with a competitive 58 advantage in the niche by suppressing the proliferation of surrounding cells. 59
Results
60
Transformed NSCs are refractory to quiescence-inducing signals. 61 To understand how transforming mutations affect the quiescent or activation status of NSCs 62
we compared NSCs derived from wild-type mice to those isolated from Ink4a/Arf -/mice and 63 transduced with a retrovirus expressing the EGFRvIII mutation (Bruggeman et al., 2007) . 64 This combination of mutations is frequently observed in human GBM (Crespo et al., 2015) 65 and induces transformation in NSCs, as indicated by their ability to generate tumours in vivo 66 that recapitulate many of the features of human GBM tumours (Bruggeman et al., 2007; 67 Marques -Torrejon et al., 2018) . We first compared the proliferative potential of both these 68 cell types. We observed that, when grown in conditions that promote the 69 activated/proliferative NSC state (Pollard et al., 2006) , transformed NCSs displayed a small 70 growth advantage ( Figure 1A) . Analysis of the prevalence of BrdU incorporation revealed 71 that this difference was most likely accounted for by a small difference in the rate of cell 72 division at day four of culture, when transformed cells divided faster (Supplementary Figure  73 1A-B). However, overall these results indicate that the pattern of proliferation of wild-type 74
and Ink4a/Arf -/-; EGFRvIII NSCs (IE-NSCs) in growth-promoting conditions was remarkably 75 similar. 76
We next investigated if IE-NSCs have a similar response to quiescence-inducing signals 77 when compared to wild-type NSCs. BMP signalling is known to induce a reversible 78 quiescent-like state in hippocampal and embryonic stem cell-derived NSCs (Martynoga et al., 79 2013; Mira et al., 2010) and the BMP antagonist Noggin enhances NSC expansion both in 80 vitro and in vivo (Lim et al., 2000; Mira et al., 2010; Yousef et al., 2015) . For this reason, we 81 treated wild-type and transformed NSCs with 50ng/ml BMP4. We observed that, although 82 this induced similar levels of SMAD1/5/8 phosphorylation in both cell types (Supplementary 83 Figure 1C ) and efficiently suppressed the proliferation of wild-type cells, it had little effect 84 on the growth of the transformed cells (Supplementary Figure 1D ). This suggests that NSCs cells are refractory to the induction of quiescence by BMP signalling activation. 86
Transformed NSCs suppress the proliferation of surrounding NSCs. 87 The experiments described above allowed us to test the proliferative potential of wild-type 88 and transformed cells as isolated cell populations. However, we postulated that in the niche 89 these cell types are likely to co-exist. For this reason, we next studied the proliferation 90 patterns of both cell types in a 50:50 co-culture and compared these proliferative patterns to 91 the growth of the cells in homotypic (separate) cultures. IE-NSCs were GFP-labelled, 92
allowing us to quantify the relative cell proliferation rates in co-culture using flow cytometry. 93
Unexpectedly, we observed that, in contrast to the exponential growth observed for both cell 94 types in separate culture, in co-culture wild-type NSCs showed a significant growth arrest 95 ( Figure 1B ). Transformed NSCs therefore do not facilitate normal NSC growth as might be 96 anticipated; rather, they deploy some active mechanism to suppress their expansion and 97 outcompete them. 98
Quantification of the fold change in cell number indicated that the wild-type NSCs increased 99 their cell number only around 15-fold over six days in co-culture, compared to more than 50-100 fold when cultured separately ( Figure 1C ). This dramatic reduction in the proliferation of 101 wild-type NSCs in the co-culture condition was also confirmed using BrdU incorporation 102 assays and quantifying expression mitotic marker phospho-Histone3 ( Figure 1D -E and 103
Supplementary Figure 1C -D). These results suggest that IE-NSCs have an inhibitory effect 104 on the proliferation of wild-type NSCs. To test this possibility further, co-cultures were 105 established with varying proportions of each cell type, ranging from 10 to 90%, and the total 106 number of cells present in co-culture was kept constant. Analysis of the fold change in wild-107 type NSC number revealed that the reduction in their proliferation was directly proportional 108 to the percentage of transformed NSCs present ( Figure 1F ), to the extent that, when 75% of immediately apparent that the majority of the top canonical pathways that were enriched in 120 this comparison were related to cell cycle control and DNA repair ( Figure 2A ) . For example,  121  the top enriched pathway was 'cell cycle control of chromosomal replication', which includes  122  important cell cycle-associated genes, such as multiple CDKs, MCM proteins and PCNA.  123 The genes in this pathway were broadly downregulated in wild-type NSCs in co-culture 124 compared to separately cultured cells ( Figure 2B ), consistent with a proliferation arrest when 125 surrounded by transformed cells. 126
One possible explanation for this cell cycle arrest is differentiation into a post-mitotic cell 127 types, such as immature neurons. Doublecortin, Olig2, S100b or Tubb3, were not upregulated ( Supplementary Figure 2A ), 133
indicating there was no increase in differentiation, an observation that was consistent with the 134 morphology of these cells that was not that of oligodentrocyte progenitor cells, 135 oligodentrocytes or neurons. Interestingly, we did observe an upregulation in the expression 136 of the glial markers, Gfap, Glt1 and Glast, which are enriched in quiescent radial glia-like 137
NSCs (Codega et al., 2014; Llorens-Bobadilla et al., 2015) . These observations suggest that 138 wild-type NSCs are not differentiating, but instead may be driven into a quiescent state. 139
To explore this last possibility we analysed our RNA-seq data-set for the expression of a 140 broader set of quiescent and activated NSC markers. We found that the quiescence-associated 141 transcriptional regulators, Sox9, Id2, Id3 and Klf9, which are upregulated in quiescent SVZ 142
NSCs (Llorens-Bobadilla et al., 2015; Morizur et al., 2018) , were all also upregulated in the 143 co-cultured wild-type NSCs ( Figure 2C ). We also observed that the markers of 144 activated/proliferating NSCs Ascl1, Egr1, Fos and Sox11 (Andersen et al., 2014; Llorens-145 Bobadilla et al., 2015; Morizur et al., 2018) were downregulated in these cells. When we 146 compared our RNA-seq data-set with a list of transcription factors and co-factors that have 147 been found to be differentially expressed between activated and quiescent SVZ NSCs 148 (Morizur et al., 2018) , we found that of the 14 genes enriched in quiescent cells in this study, 149 10 were upregulated in co-cultured wild-type NSCs, and of the 61 genes enriched in activated 150
NSCs, 50 were downregulated (Supplementary Figure 2B ). Together these findings therefore 151 support the hypothesis that the co-cultured NSCs are adopting a quiescent phenotype rather 152 than becoming senescent. 153
A key feature of a quiescent phenotype is its reversibility. To test if the proliferation arrest of 154 wild-type NSCs in co-culture is reversible, we sorted wild-type and transformed cells after 5 155 days in co-culture and re-plated them. In parallel, wild-type NSCs that had been cultured 156 separately were mixed with transformed cells just before sorting and then re-plated. 157
Importantly, we observed that previously co-cultured wild-type NSCs displayed a similar 158 proliferation rate to NSCs that had been separately cultured throughout, as judged by their 159 growth curves and rate of BrdU incorporation (Figure 2E -F). The reversible nature of the 160 proliferation arrest of co-cultured wild-type NSCs provides further evidence that they are 161 entering a quiescent state. 162
Cell contact is required for the inhibitory effect of transformed cells 163
To understand the mechanisms underlying the interaction between wild-type and transformed 164
NSCs, we first analysed the possible involvement of the mTOR signalling pathway. mTOR is 165 a metabolic regulator that senses growth factor and nutrient inputs, is activated in transit 166 amplifying progenitor cells and its inhibition induces a reversible quiescence-like phenotype 167 in adult NSCs (Paliouras et al., 2012) . Analysis of the expression of ribosomal protein S6 168 phosphorylation (p-S6), a read-out of mTOR activity indicated that mTOR signalling levels 169
were reduced in the co-cultured wild-type NSCs, not only relative to these same cells in 170 separate culture, but also to transformed NSCs in co-culture ( Figure 3A ). We next tested if 171 constitutive mTOR activation was sufficient to prevent these wild-type NSCs from entering 172 quiescence in co-culture. For this we mutated Tsc2, an mTOR repressor in wild-type NSCs, 173
using CRISPR-Cas9 targeting (Supplementary Figure 2C ). However, we found that, although 174 this was sufficient to sustain strong mTOR pathway activation, Tsc2 -/-NSCs still entered a 175 proliferation arrest when co-cultured with transformed NSCs (Supplementary Figure 2D -F). 176
This indicates that mTOR inhibition is not the primary reason for the quiescent phenotype of 177 co-cultured wild-type NSCs. 178
Next, we investigated an alternative possibility that cell contact is required to induce the 179 growth arrest of wild-type NSCs. We first used a transwell assay, where the two cell types 180 are cultured in the same well, separated by a permeable membrane that allows the exchange 181 of factors in the media while physically separating the cells. When wild-type cells were co-182 cultured with transformed cells separated by a transwell, they grew similarly to wild-type 183 cells in homotypic cultures ( Figure 3B ). This suggests a requirement for cell-cell contact and 184 that secreted paracrine factors are not sufficient to induce the quiescence. We further tested 185 this possibility by using fences, which are metal inserts that divide the well into an inner and 186 outer ring One cell type is plated in the inner ring and the second in the outer ring ( Figure 3C ) 187 and once they are growing adherently, the inserts can be removed leaving behind a small gap 188 between the two populations. Using this system we compared the proliferation rate of wild-189 type NSCs that were separated from transformed NSCs to their proliferation when separated 190 from other wild-type NSCs or when mixed with transformed cells. We found that the rate of 191
BrdU incorporation of the wild-type NSCs only decreased when these cells were in physical 192 contact with transformed cells ( Figure 3C ). This indicates that cell-cell contact is most likely 193 required for transformed cells to inhibit the proliferation of wild-type NSCs. 194
Transformed cells signal via Notch and Rbpj to induce quiescence in wild-type NCSs 195
The Notch pathway is a highly conserved signalling pathway requiring cell-cell contact that 196 plays a central role in the regulation of embryonic and adult neurogenesis (Ables et al., 2011; 197 Urban and Guillemot, 2014). To test the potential role for Notch signalling we first explored 198 the expression of Notch signalling pathway components in our RNA-seq data. Interestingly, 199 genes related to the Notch signalling pathway were enriched in the comparison between co-200 cultured wild-type and transformed NSCs (p-value = 5.94E -6 , 21/38 genes differentially 201 expressed with adjusted p-value <0.1). Overall, the majority of Notch-related genes were 202 upregulated in wild-type NSCs compared to transformed NSCs, including Notch targets and 203 receptors, while there was some evidence that Notch ligands were more highly expressed on 204
transformed NSCs in co-culture ( Figure 3D ). Analysis by real-time qPCR of sorted samples 205 also revealed that the expression of the Notch target genes Hes1, Hes5, Hes7, Hey1, Hey2 206 and Nrarp are upregulated in co-cultured wild-type NSCs ( Figure 3E ). This suggests that 207
Notch pathway activity is higher in co-cultured wild-type NSCs than in transformed cells and 208 raises the possibility that transformed cells may be signalling to wild-type NSCs via this 209
pathway. 210
To test the functional significance of this difference in Notch activation, two complementary 211 γ -secretase inhibitors were used to block Notch signalling. We observed that both LY411575 212
(LY) and crenigacestat not only reduced Notch target gene expression in NSCs, but also 213 partially rescued the proliferation arrest of wild-type NSCs in co-culture with transformed 214 cells. Evidence for this is that the growth curves and BrdU incorporation rates of co-cultured 215
NSCs treated with the γ -secretase inhibitors were only slightly lower than their growth is 216 separate culture ( Figure 3G -H and Supplementary Figure 3A -E). This suggests that Notch 217 signalling is required for the induction of quiescence in wild-type NSCs by transformed cells. 218
To further test the requirement of Notch signalling in wild-type NSCs we mutated Rbpj, a 219 key effector of this pathway, as well as Notch1 and Notch2 by CRISPR/Cas9 targeting 220 ( Figure 4A , D and G). Importantly, we found that Rbpj -/-, Notch1 -/or Notch2 -/-NSCs were 221 not susceptible to proliferation arrest when co-cultured with IE-NSCs. For example, we 222 observed that all three Notch pathway mutant cell lines displayed similar growth rates in 223 separate and co-culture (Supplementary Figure 4A-D) . Similarly, the fold change in cell 224 number and BrdU incorporation rates of co-cultured Rbpj -/-, Notch1 -/and Notch2 -/-NSCs was 225 similar to separate culture and significantly higher than that of wild-type NSCs co-cultured 226 with IE-NSCs ( Figure 4B -C, E-F and H-I). Interestingly, both the growth curves and final 227 cell counts of Rbpj -/-NSCs indicated that these cell types even out-grew IE-NSCs in co-228 culture ( Figure 4B and Supplementary Figure 4B ), suggesting that disrupting Notch 229 signalling may be sufficient to provide NSCs with a competitive advantage against 230 transformed NSCs. Together, these data indicate that Notch signalling is required for the 231 suppression of proliferation of wild-type NSCs by transformed cells. 232
Finally, to exclude the possibility that Notch signalling is required in transformed NSCs, we 233 mutated Rbpj in this cell type (Supplementary Figure 4E ). We observed that IE-NSCs still 234
induced the proliferation arrest of wild-type NSCs, as shown by the growth curves, final cell 235 numbers and rate of BrdU incorporation (Supplementary Figure 4F -H). Therefore Notch 236 signalling is not required in transformed cells for their growth inhibition of wild-type NSCs. 237
Discussion
238
In conclusion, our data indicate that transformed cells activate Notch signalling in adjacent 239 wild-type NSCs to induce in these a quiescent state. Importantly, the role of Notch signalling 240 in regulating the activated versus quiescent state of NSCs is borne out by the work of others. 241
Increased expression of Notch signalling pathway components in quiescent NSCs compared 242
to activated NSCs has been widely reported in RNA-sequencing studies (Andersen et al., 243 2014; Llorens-Bobadilla et al., 2015; Morizur et al., 2018) . Additionally, NOTCH receptor 244 and RBPJ expression have been previously confirmed in both quiescent and activated NSC 245 populations in the SVZ, and NOTCH2 has been shown to mediate signals promoting NSC 246 quiescence within the niche (Engler et al., 2018) . The Notch ligand Dll1 has also been 247
reported to be expressed exclusively in activated NSCs and transit-amplifying cells 248 (Kawaguchi et al., 2013) and its deletion resulted in excessive production of activated NSCs 249 and a depletion of the quiescent NSC pool. Similar observations have also been made in 250 zebrafish, where activated radial glial cells were shown to revert to a quiescent state by Notch 251 pathway activation (Chapouton et al., 2010) . Therefore our results imply that transformed 252 cells highjack an evolutionarily conserved pathway regulating vertebrate NSC quiescence 253
and use it to gain a competitive advantage over other NSCs in the niche. 254
Our work also has implications for glioblastoma tumour progression. The SVZ has been 255
shown to be a permissive region for glioblastoma growth, as tumours in contact with this 256 region are associated with decreased patient survival and increased recurrence (Khalifa et al., 257 2017; Mistry et al., 2017) . This niche has also been suggested to serve as a reservoir for 258 malignant cells away from the tumour mass and may therefore support tumour recurrence 259 (Piccirillo et al., 2015) . In humans it has been shown that glioblastoma can arise from SVZ 260 cells with low-level driver mutations (Lee et al., 2018), further highlighting the importance of 261 the SVZ for oncogenic cell propagation. We therefore speculate that the mechanisms we 262 describe operate during early premalignant disease to support tumorigenesis. Here, 263
transformed NSCs provide negative feedback signals to surrounding normal NSCs limiting 264 their self-renewal and enforcing their quiescence. By this mechanism, oncogenic NSCs can 265 ensure their preferential self-renewal and differentiation, therefore increasing both their cell 266 number and their likelihood of giving rise to progenitor cells and exiting the niche. This 267 competitive advantage may be an important early step in the development of glioma and 268 glioblastoma and therefore understanding it may help develop therapeutic approaches. 269
Materials and Methods
270
Neural Stem Cell Cultures 271
Adult murine NSCs were derived from the SVZ by the protocol described in [5] . 272
Transformed Ink4a/Arf -/-; EGFRvIII NSCs (IE-NSCs) were generated by the Maarten van 273
Lohuizen laboratory (Netherlands Cancer Institute). NSCs were isolated from Ink4a/Arf -/-274 mice and transduced with EGFRvIII pMSCV retrovirus (Bruggeman et al., 2007) . All cells 275
were cultured at 37°C in an atmosphere with 5% CO2. NSCs were maintained in serum-free 276 adherent growth conditions on poly-L-lysine-coated plates (Sigma). 1µg/ml Laminin (Sigma)  277 was also added to the growth media to promote adherent growth. Growth medium was 278
Dulbecco's Modified Eagle Medium: Nutrient Mixture F12 (DMEM/F12) (Gibco) 279 supplemented with N2 (1:200, Invitrogen), B27 (1:100, Invitrogen), 1x non-essential amino 280 acids (Invitrogen), 0.1% BSA (Gibco), 100µM β -mercaptoethanol (Invitrogen), 1.5mg/ml 281 glucose (Sigma), 15mM HEPES (Gibco), 2mM L-glutamine (Gibco), 100U/ml penicillin-282 streptomycin (Gibco), 20ng/ml EGF and 10ng/ml bFGF (both Peprotech). 283
Co-culture assays 284
For six-day co-culture assays, 40,000 cells per well were seeded in a 24-well plate either 285 separately or as a 50:50 mix of WT and transformed NSCs. Standard growth media was used 286 throughout and was changed on days three, four and five. The proportion of each cell type 287 was assessed by determining the percentage of GFP-positive cells by flow cytometry. Cells 288
were harvested with accutase and resuspended in PBS containing 3% FCS. All samples were 289 transferred into strainer-cap flow cytometer tubes for analysis and 100ng/ml propidium 290 iodide (PI) was added. Flow cytometry was performed on an LSR-II Analyser (BD 291
Biosciences) with FACS Diva software (BD Biosciences). Gates were applied to exclude 292 cellular debris, cell doublets and non-viable PI-positive cells. The percentage of GFP-positive 293
and GFP-negative cells was determined with gates set using separate cell preparations. 294
Separate cultures were also mixed and analysed by flow cytometry. Viable cell counts at each 295 time point were performed using a Vi-Cell XR counter (Beckman Coulter) and calculated for 296 each cell type in separate and co-culture by applying the percentages from the flow cytometry 297
analysis. 298
For transwell assays, cell culture inserts with 0.4µm pores (Merck Millipore) were placed in a 299 6-well plate and coated with PLL. 140,000 NSCs were seeded in NSC growth media either 300 onto the insert or below in the well. The growth of WT NSCs seeded below either WT or 301
transformed NSCs or a 50:50 mix was evaluated over six days. For fence assays, 24-well 302 plates were coated with PLL and fences (Aix-Scientifics) were placed in each well. 100,000 303
NSCs were seeded in the inner ring and 400,000 in the outer ring. The fences were removed 304 24 hours later and the media was replaced. The following day, 10µM BrdU was added to the 305 wells for two hours. The fences were then replaced into the well and the cells in the inner ring 306
were detached with accutase and harvested. The cells were then fixed in 2% formaldehyde 307 and analysed for BrdU expression by flow cytometry as described below. 308
Flow cytometry immunolabelling 309
Cells were fixed in 2% formaldehyde and permeabilised in ice-cold 90% methanol. Cells 310
were incubated with the primary antibody (anti-p-rpS6, CST 5364, recovered post-transfection with pre-warmed NSC growth media into a 10cm 2 dish. Selection 387 with 0.25ug/ml puromycin or 250ug/ml hygromycin was performed from 48 hours post-388 transfection until the emergence of resistant colonies. These were then picked manually with 389 a p20 pipette and transferred to a 48 well plate for expansion and analysis. 390 Data and Code availability 398 The raw data for the RNA-sequencing of wild-type and transformed NSCs are being 399 deposited in the arrayexpress database and an accession code that will be made available 400
Quantification and Statistical Analysis
prior to acceptance. The authors declare that all data supporting the findings of this study are 401 available within the article and its supplementary information files or from the corresponding 402 author upon reasonable request. 403 Acknowledgments 406 We would like to thank Stephen Rothery for guidance and advice with confocal microscopy. 407
Key Resources
Gratitude also goes to James Elliot for performing cell sorts. Research in Tristan Rodriguez 408 lab was supported by the MRC project grant (MR/N009371/1), by the Rosetrees Trust grant 409 (M693) and by the British Heart Foundation centre for research excellence. Katerina Lawlor 410 was supported by an NHLI PhD studentship. 411
Conflicts of interests 412
The authors declare no competing financial or non-financial interests. 413 414 profiling studies that sought to compare quiescent and activated NSCs. Quiescence-441 associated genes were broadly upregulated in the co-cultured NSCs, while activation-442 associated genes were broadly downregulated. D Growth curves showing cell numbers for 443 three days following replating. E Proportion of BrdU-positive cells at day three after re-444 plating. No difference could be found in the growth of WT NSCs which had previously been 445 co-cultured compared to cells grown separately. N=3. D and E WT NSCs were cultured for 5 446 days either in co-culture or separately and then sorted by FACS and replated at 100,000 447 cells/well. 448 and mixed culture and quantification of median fluorescence intensity. WT NSCs show 452 reduced expression specifically in the co-culture condition. N=6, ANOVA followed by 453
Figure Legends
Sidak's multiple comparisons test. B Growth curves of WT NSCs cultured below transwell 454 inserts with WT, transformed or mixed cultures. No difference was observed between 455 conditions. N=3. C Percentage of BrdU-positive WT NSCs from the inner ring of the three 456 different cultures shown. When cells were mixed in each well WT NSCs showed a decrease 457 in the proportion of proliferating cells (Mix/Mix). However, WT NSCs surrounded by a ring 458 of transformed NSCs (Trans/WT) did not show a reduction in proliferation relative to WT 459
NSCs surrounded by WT NSCs (WT/WT Cas9 and Tsc2 -/clones as determined by flow cytometry. mTOR activation is increased in 518
Tsc2 -/-NSCs and remains high in co-culture despite reduced growth. N=3. 519
Supplemental Figure 3 520
A RT-qPCR analysis of the Notch target genes, Hes1, Hes5 and Nrarp in WT NSCs treated 521 with 2µM LY411575. Log 2 fold change relative to control NSCs. N=3. B Growth curves of 522
WT and transformed NSCs cultured in the standard assay with or without LY411575 addition 523 from day three. C RT-qPCR analysis of the Notch target genes, Hes1, Hes5 and Nrarp in WT 524
NSCs treated with 1µM crenigacestat. Log 2 fold change relative to control NSCs. N=3. D 525
Growth curves of WT and transformed NSCs cultured in the standard assay with or without 526 crenigacestat addition from day three. N=8, two-way ANOVA followed by Sidak's multiple 527 comparisons test. E Proportion of BrdU positive cells following a 24 hour incubation with 528 crenigacestat. N=4, two-way ANOVA with Sidak's multiple comparisons test. The γ -529 secretase inhibitor crenigacestat also increases WT NSC proliferation in co-culture. 530
Supplemental Figure 4 531
A Growth curves of control EV clone cultured separately or in co-culture with transformed 532
NSCs. B Growth curves of Rbpj -/clones cultured separately or in co-culture with 533
transformed NSCs. C Growth curves of Notch1 -/clones cultured separately or in co-culture 534 with transformed NSCs. D Growth curves of Notch2 -/clones cultured separately or in co- 
